1. Pharmaceuticals and Drug Development

Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma

Written by Posted on Less than 0 min read

WOBURN, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the U.S. Food and Drug Administration…

Member since

More from Admin

Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Large differences in water-seeking ability found in U.S. corn varieties

A corn plant knows how to find water in soil with the very tips of its roots, but some varieties, including many used for breeding high-yielding corn in the U.S., appear to have lost a portion of that ability, according to a Stanford-led study. With climate change increasing droughts, the findings hold potential for developing […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

CRISPR/Cas9 modifies euglena to create potential biofuel source

News about biofuels sometimes mentions used cooking oil as a feedstock, but if these substances contain animal fat, they can solidify in colder temperatures. This happens because, chemically, the fatty acids of these and many other saturated fats have long carbon chains with single bonds. Enter the euglena. An Osaka Metropolitan University team has found […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Novel molecular maneuver helps malaria parasite dodge the immune system

Researchers at Weill Cornell Medicine have discovered how a parasite that causes malaria when transmitted through a mosquito bite can hide from the body’s immune system, sometimes for years. It turns out that the parasite, Plasmodium falciparum, can shut down a key set of genes, rendering itself “immunologically invisible.” “This finding provides another piece of […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

AI-designed DNA controls genes in healthy mammalian cells for first time

A study published today in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells. Researchers at the Centre for Genomic Regulation (CRG) created an AI tool which dreams up DNA regulatory sequences not seen before in nature. The model can […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Giant croclike carnivore fossils found in the Caribbean

Imagine a crocodile built like a greyhound — that’s a sebecid. Standing tall, with some species reaching 20 feet in length, they dominated South American landscapes after the extinction of dinosaurs until about 11 million years ago. Or at least, that’s what paleontologists thought, until they began finding strange, fossilized teeth in the Caribbean. “The […]
Written by
2 million-year-old teeth reveal secrets from the dawn of humanity
  1. Life Sciences

2 million-year-old teeth reveal secrets from the dawn of humanity

For nearly 100 years, scientists have been intrigued by the fossils of Paranthropus robustus, a sturdy, distant cousin of early humans. This upright-walking hominin was built for chewing tough foods, equipped with powerful jaws and large teeth coated in thick enamel. Researchers believe it lived in southern Africa between 2.25 million and 1.7 million years […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Feeding grazing cattle seaweed cuts methane emissions by almost 40%

Seaweed is once again showing promise for making cattle farming more sustainable. A new study by researchers at the University of California, Davis, found that feeding grazing beef cattle a seaweed supplement in pellet form reduced their methane emissions by almost 40% without affecting their health or weight. The study was published today (Dec. 2) […]
Written by
Sunflowers may be the future of "vegan meat"
  1. Life Sciences

Sunflowers may be the future of "vegan meat"

A collaboration between Brazilian and German researchers has led to a sunflower-based meat substitute that’s high in protein and minerals. The new ingredient, made from refined sunflower flour, delivers excellent nutritional value and a mild flavor. Tests showed strong texture and healthy fat content, suggesting great potential for use in the growing plant-based food sector. […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Is fake meat good to eat? Processed plant-based meat alternatives linked to depression risk in vegetarians

There is mounting evidence suggesting that ultra processed foods (UPF) are bad for our health; but if you stick to a vegetarian diet, is that still the case? Plant-Based Meat Alternatives (PBMA) are considered to be ultra-processed foods and may be associated with similar harms. In the first study of its kind, published in Food […]
Written by
  1. Biology

Exploring the impact of attentional uniqueness and attentional allocation

According to the attention-based view, a firm’s actions and growth performance are directly influenced by its attentional allocation to specific issues. The consequences of organizational attention are reflected in the firm’s strategic decision-making and adaptability. However, existing literature is limited in its exploration of how a firm’s attentional uniqueness impacts its behavior and performance. Notably, […]
Written by
  1. Biology

PITPβ promotes COPI vesicle fission through lipid transfer and membrane contact formation

Intracellular transport among organellar compartments occurs in two general ways: by membrane-bound carriers and membrane contacts. Specific circumstances that involve the coordination of these two modes of transport remain to be defined. By studying coat protein I (COPI) transport, we find that phosphatidylcholine with short acyl chains (sPC) is delivered through membrane contact from the […]
Written by
  1. Pharmaceuticals and Drug Development

Stealth Biotherapeutics Announces FDA Acceptance of Elamipretide NDA Resubmission

NEEDHAM, Mass., Aug. 21, 2025 /PRNewswire/ — Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction… Admin Member since October 11, 2023 Loading + Follow Following
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon PTH for Adults with Hypoparathyroidism

Generic name: palopegteriparatideTreatment for: Hypoparathyroidism Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon PTH for Adults with Hypoparathyroidism COPENHAGEN, Denmark, May 14, 2024 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food and Drug Administration (FDA) notified the Company that information submitted in response […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Post Hoc Analysis Showed CIMZIA Resulted in Meaningful Efficacy for RA Patients with High Levels of Rheumatoid Factor (RF)

ATLANTA, Nov. 11, 2023. CB, a global biopharmaceutical company, will present a post hoc analysis of the EXXELERATE trial examining the efficacy of CIMZIA (certolizumab pegol) and adalimumab in patients with rheumatoid arthritis (RA) with high rheumatoid factor (RF) levels. The data are being presented at the American College of Rheumatology (ACR) Convergence 2023 in […]
Written by
ADaM: The Unsung Hero of Clinical Trial Data Analysis
  1. Clinical

ADaM: The Unsung Hero of Clinical Trial Data Analysis

IntroductionImagine you’re a researcher working on a groundbreaking clinical trial. You’ve collected mountains of data, but now comes the hard part—making sense of it all. Enter ADaM, the Analysis Data Model developed by CDISC. ADaM is the unsung hero that transforms raw data into actionable insights, ensuring your trial meets regulatory standards and delivers reliable […]
Written by
  1. Clinical

Approval for the First Dose Cohort in Phase 1a/b Clinical Trial of PMC-309 in Patients with Advanced or Metastatic Solid Tumors

DAEJEON, South Korea, July 8, 2024. PharmAbcine Inc., a clinical-stage biotech company focusing on next-generation antibody therapeutics, announced that PMC-309, VISTA-targeting immuno-oncology program, received safety approval for the first dose cohort (0.2mg/kg) in Phase 1a/b clinical trial for patients with advanced or metastatic solid tumors in Australia. The second dose cohort (0.5mg/kg) is currently ongoing. […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

NIH Researchers Develop Approach That Could Help Supercharge T-Cell Therapies Against Solid Tumors

November 1, 2023 — Researchers at the National Institutes of Health have developed a way to potentially increase the effectiveness of T cell–based immunotherapy treatments, such as CAR T-cell therapy, against solid tumors. T cells are specialized white blood cells of the immune system that eliminate infected or abnormal cells. In animal studies, the enhanced […]
Written by
  1. Clinical

New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl

LUND, Sweden, June 25, 2024. Camurus today announced the publication in JAMA Network Open of a new post hoc analysis from a 24-week randomized, double-blind, Phase 3 study1 comparing weekly and monthly subcutaneous (SC) buprenorphine injections (Buvidal/Brixadi) to daily sublingual buprenorphine/naloxone (SL-BPN/NX). The data presented suggests the effectiveness in individuals with opioid dependence who use […]
Written by
Next
No Comments
Leave a comment Cancel
Comments to: Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.